Руководство WSAVA

  • View
    216

  • Download
    2

Embed Size (px)

DESCRIPTION

РуководствоРуководствоРуководствоРуководствоРуководствоРуководство

Transcript

  • WSAVA

    (2010)

    ( )

  • 1

    WSAVA (2010) (VGG) (WSAVA). VGG, : M.J. Day, M.C. Horzinek, R.D. Schultz

    Guidelines for the Vaccination of Dogs and Cats (2010) : Journal of Small Animal Practice, 2010, v. 51, pp. 338-356; WSAVA: http://www.wsava.org/guidelines/vaccination-guidelines.

    .. , .. (2014 .) , . ..

    2

    3

    4

    WSAVA (2010) 5

    1. 5

    2. 6

    3. 7

    4. 8

    5. 8

    6. 13

    7. 15

    8. 16

    9. I. ( )

    10. II. 24

    11. III. ( )

    , VGG ( WSAVA)

    35

    ( )

    36

  • 2

    (WSAVA) WSAVA . . , , , (DOI), .

    WSAVA, . . , .

    .. , ..

  • 3

    / ;

    / ;

    / ;

    / ;

    / ;

    AC (Artificial Colostrum) ;

    AHCh (Annual Health Check) ;

    ALB (Avirulent Live Bacterin) vaccines ;

    CAV (Canine AdenoVirus) ;

    CCV (Canine CoronaVirus) ;

    CDV (Canine Distemper Virus) ;

    CIV (Canine Influenza Virus) ;

    CPiV (Canine Parainfluenza Virus) ;

    CPV-2 (Canine ParvoVirus type 2) 2;

    DOI (Duration Of Immunity) ; FAQs (Frequently Asked Questions) ;

    FCoV (Feline CoronaVirus) ;

    FCV (Feline CaliciVirus) ;

    FeLV (Feline Leukemia Virus) ;

    FHV-1 (Feline HerpesVirus-1) -1;

    FIP (Feline Infectious Peritonitis) ;

    FISS (Feline Injection Site Sarcoma) ;

    FIV (Feline Immunodeficiency Virus) ;

    FPV (Feline ParvoVirus) ;

    KB (Killed Bacterin) vaccines () ;

    KV (Killed Virus) vaccines () ;

    MDA (Maternally Derived Antibody) ;

    MLV (Modified Live Virus) vaccines ;

    OspA (Outer surface protein A) A;

    PETS (Pet Travel Scheme) ;

    RV (Rabies Virus) ;

    VGG (Vaccination Guidelines Group) , ;

    WSAVA (World Small Animal Veterinary Association) .

  • 4

    R Rabies Virus (RV)

    Bb Bordetella bronchiseptica

    F TM Trichophyton spp. Microsporum spp.

    ( )

    D Canine Distemper Virus (CDV)

    H A Canine AdenoVirus (CAV-1 CAV-2)

    P Canine ParvoVirus (CPV-2)

    C Canine CoronaVirus (CCV)

    Pi Canine Parainfluenza Virus (CPiV)

    L Leptospira spp.

    P Feline ParvoVirus (FPV)

    Panleukopenia Virus

    R H Feline HerpesVirus (FHV-1)

    C Feline CaliciVirus (FCV)

    Ch Chlamydia spp. Chlamydophila spp.

  • 5

    WSAVA (2010)

    1.

    VGG (WSAVA) 2006 , () . VGG 2007 ( ). , , -2007 ,

    . , 2010 , -2010.

    ( VGG) , ( ) .

    , . , (herd immunity), .

    VGG (core), (non-core), (not recommended).

    (core) ( , ).

    : (CDV); (CAV); 2 (CPV-2).

    : (FPV); (FCV); -1 (FHV-1).

    (RV) , .

    (MDA) . MDA , VGG 3 , 14-16 . , (core) 16 .

    , . (core) / 12 ( ). , 1 3 , (DOI) ( ).

  • 6

    (non-core) , . , (non-core), (AHCh), DOI 1 .

    , VGG (not recommended) , . , (minority products), .

    , , VGG . , (core) . , 1 (. 2, 4).

    VGG .

    VGG .

    -2010: (core) , (non-core) .

    2.

    VGG , . VGG 2009 2007 , . ( ) WSAVA.

    , -2007 , VGG 70 - WSAVA . :

    1. WSAVA 2007 ?

    2. -2007 ?

    3. ?

    4. , 2007 ? 5. - WSAVA

    ?

  • 7

    , , VGG .

    27 .1 , . 12 27 -2007 . 13 27 , VGG 6 . 14 , , 12 -2007 , .

    , VGG. , .

    . 2010 :

    1. . 2. , . 3. (CIV),

    (leishmaniosis) (malignant melanoma). 4. ,

    (FHV-1 FCV), (FeLV).

    5. . 6.

    2c (CPV-2c). 7. (fact sheet) . 8. (FAQs).

    , -2007 .

    9. ,

    . .

    3.

    (data sheet), , . , (). DOI , DOI . DOI 1 , . ( 3 ) (, , DOI). (core) DOI 3 .

    1 , ( ).

  • 8

    1 3 , DOI 1 . , , ( 20 ). , ( !) ( off-label use2- ).

    4.

    VGG : , ?

    : (core)

    , . , 30-50 % . , (herd immunity): , .

    , . , .

    5.

    VGG 1. (core) , . .

    , , . (non-core) .

    12 (MDA) . , , 8-12 . MDA ,

    , . MDA 12 . , VGG 8-9 , 3-4 , 14 16 . 2- 3- .

    2 Off-label use ; , .

  • 9

    ( ) 10 , . VGG - 14-16 , .

    ( ) . ( T- B-) , . - MDA (, , ).

    12 . , () .

    ,

    (MLV-vaccines) (core) . 12 () , VGG , 1 3 . (core) (non-core) ( ). , Leptospira, Bordetella, Borrelia (Lyme disease) (CPiV) .

    VGG , ( ), (core + non-core), .

    ( 12 ) , . ( ), . , .

    CDV, CPV-2, CAV-1 . ( ) ( -).

    , 2 () , / ( ).

  • 10

    . - , (non-responder).3

    .

    - :

    : 1. MDA .

    14-16 98 % .

    2. . , , , , , .

    3. . , 80- CPV-2 . , non-responder. CPV-2 , . non-responder,

    CPV-2 /, (PETS).

    3 Non-responder , .

  • 11

    DOI (core) . / (memory effector B cells). . (core) , (non-core) (Leptospira CPiV). , / (core) .

    , CDV, CPV-2, CAV-1 CAV-2 3 . / , - .

    , . , VGG , , .

    , , / (viral load) . ( , ) , . - / . ( ) , .

    . , , / , ( ).

    , ( , , ). ( ), ( ) , , ( ) .

    CDV. ( , .) ( ), . .

  • 12

    FPV CPV-2 , . / 24-48 . .

    () . , . . VGG .

    VGG , ( ).

    (CIV)

    2009 . Influenza A

    subtype H3N8 , . 6- 2-4 , , . 7 2- . (non-core).

    (leishmaniosis), GP63 ( fucose mannose ligand) Leishmania donovani , , , . / , Leishmania . , 1,3 % . , () , . (core) , .

    (malignant melanoma) 2007 2010. - ( , ) . , , . II-IV 90 389 .4 .

    4 P.J. Bergman, M.A. Camps-Palau, J.A. McKnight, N.F. Leibman, D.M. Craft, C. Leung, J. Liao, I. Riviere, M.

    Sadelain, A.E. Hohenhaus, P. Gregor, A.N. Houghton, M.A. Perales and J.D. Wolchok. Development of a

    xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Centre. Vaccine,

    2006, v. 24, pp. 4582-4585.

  • 13

    6.

    (core), (non-core) (not recommended) 3. (core) , FCV FHV-1 , FPV. (core) , .

    FCV , . FHV-1 , , () . . , . VGG FCV FHV-1, , . . VGG FeLV (non-core) .

    12 , (MDA). , , / , . , MDA , , 8-12 . 8-9 3-4 . MDA , VGG 14-16 . , (core) 3 : 8-9 , 3-4 14-16 .

    ( ) , 12 . , . 1 3 . (core) 1 .

    (core) (MLV-vaccines) - . (core) (non-core) ( ). Chlamydophila Bordetella .

  • 14

    VGG , ( ), (core + non-core), (core) (non-core) .

    ( 12 ) , . ( ), . , .

    20 ,

    (FISS) FeLV. FISS ( / ) . - (). FeLV , FISS . FeLV , . FISS (1990-1996) (1997-2006) , FISS , ( !) . , . , . .

    FISS :

    .

    ( ) ( ), , . ( ) .